Preparation method and use of liquid embolism agent having drug loading and developing functions

Abstract

The invention discloses a preparation method and a use of a liquid embolism agent having drug loading and developing functions. The liquid embolism agent is formed through mixing anion-modified polyethylene-polyvinyl alcohol copolymer (EVOH), a solvent and a developer according to a certain ratio. Negative ion groups are introduced to the high molecular chain of the EVOH through a chemical modification or grafting modification technology, and the negative ion groups can adsorb and load cationized chemotherapeutic anticancer drugs through positive and negative charge interactions. The solvent can be dimethyl sulfoxide (DMSO), N-methylpyrrolidone (NMP) or ethanol or a mixture of the DMSO, NMP and ethanol. The developer is a metallic tantalum micro-powder or an iodine-containing contrast agent or a mixture of the metallic tantalum micro-powder and the iodine-containing contrast agent. The liquid embolism agent can be widely applied to interventional embolization therapy, and is especiallysuitable for transcatheter arterial chemoembolization (TACE) therapy of liver cancer.

Description

Technical field [0001] The invention belongs to the field of TACE, Trans Arterial Chemo Embolization (Trans Arterial Chemo Embolization), and specifically relates to a preparation method and application of a liquid embolization agent capable of carrying medicine and having both visual properties. Background technique [0002] TACE, Trans Arterial Chemo Embolization (Trans Arterial Chemo Embolization) was first proposed by Japanese scholar Yamada in 1997. It was first used in the treatment of liver cancer, and now it has become the mainstream treatment option that more than 90% of patients with liver cancer in the middle and late stages will choose. It refers to the targeted infusion of embolic agents into the tumor focus through the femoral artery, abdominal aorta, and hepatic aorta under X-rays. The embolic agent embolizes and blocks the blood supply artery of the tumor. After the blood supply of the tumor tissue is blocked, the tumor cannot get the necessary nutrients for grow...

AI Technical Summary

Problems solved by technology

These microspheres can embolize in the blood vessels for a long time without being degraded by the human body, so they will stay in the patient's body forever, forming a permanent embolism; moreover, the development and administration of most microspheres are carried out separately, that is to say, after separate After the microspheres and contrast agent are injected into the patient's body, the separation and disjoint of the microspheres and contrast agent may occur, so that the specific position of the microspheres cannot be accurately observed

Simply put, so far there is still no microsphere with its own developing performance.

In addition, imported microspheres are expensive and unbearable for patients

Images